Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment.

As more people live longer, doctors are seeing an increase in the number of people with age-related eye problems.

Key factors fueling this trend include increased awareness, improved healthcare infrastructure, and enhanced diagnostic and treatment accessibility. With the prevalence of high myopia projected to ...

The research team used data from 1990 to 2021 to analyze the prevalence of vision loss due to macular degeneration and the resulting changes in the burden of health loss. Macular degeneration is a ...

Discover the best foods and essential vitamins that protect your vision, prevent eye strain, and support lifelong eye health ...

In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.

This systematic review comprehensively summarizes treatment approaches for all types of age-related macular degeneration (AMD ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two major causes of blindness: wet age-related macular degeneration and diabetic ...

Maintaining good eyesight is essential for quality of life, and while many people focus on eating foods that improve vision, it’s just as important to avoid foods that may harm it. Certain ingredients ...

The vision research community rallies to protect the National Eye Institute from funding cuts, emphasizing its vital role in preventing blindness and advancing treatments.